Literature DB >> 28402427

BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction.

Hadar Segal-Gavish1, Neta Gazit2, Yael Barhum1, Tali Ben-Zur1, Michal Taler3, Shay Henry Hornfeld3, Irit Gil-Ad3, Abraham Weizman3,4, Inna Slutsky2, Minae Niwa5, Atsushi Kamiya5, Akira Sawa5, Daniel Offen1, Ran Barzilay1,4.   

Abstract

Cannabis abuse in adolescence is associated with increased risk of psychotic disorders. Δ-9-tetrahydrocannabinol (THC) is the primary psychoactive component of cannabis. Disrupted-In-Schizophrenia-1 (DISC1) protein is a driver for major mental illness by influencing neurodevelopmental processes. Here, utilizing a unique mouse model based on host (DISC1) X environment (THC administration) interaction, we aimed at studying the pathobiological basis through which THC exposure elicits psychiatric manifestations. Wild-Type and dominant-negative-DISC1 (DN-DISC1) mice were injected with THC (10 mg/kg) or vehicle for 10 days during mid-adolescence-equivalent period. Behavioral tests were conducted to assess exploratory activity (open field test, light-dark box test) and cognitive function (novel object recognition test). Electrophysiological effect of THC was evaluated using acute hippocampal slices, and hippocampal cannabinoid receptor type 1 and brain-derived neurotrophic factor (BDNF) protein levels were measured. Our results indicate that THC exposure elicits deficits in exploratory activity and recognition memory, together with reduced short-term synaptic facilitation and loss of BDNF surge in the hippocampus of DN-DISC mice, but not in wild-type mice. Over-expression of BDNF in the hippocampus of THC-treated DN-DISC1 mice prevented the impairment in recognition memory. The results of this study imply that induction of BDNF following adolescence THC exposure may serve as a homeostatic response geared to maintain proper cognitive function against exogenous insult. The BDNF surge in response to THC is perturbed in the presence of mutant DISC1, suggesting DISC1 may be a useful probe to identify biological cascades involved in the neurochemical, electrophysiological, and behavioral effects of cannabis related psychiatric manifestations.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28402427      PMCID: PMC6251614          DOI: 10.1093/hmg/ddx139

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  44 in total

1.  Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.

Authors:  Takatoshi Hikida; Hanna Jaaro-Peled; Saurav Seshadri; Kenichi Oishi; Caroline Hookway; Stephanie Kong; Di Wu; Rong Xue; Manuella Andradé; Stephanie Tankou; Susumu Mori; Michela Gallagher; Koko Ishizuka; Mikhail Pletnikov; Satoshi Kida; Akira Sawa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-03       Impact factor: 11.205

Review 2.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

3.  Recreational Cannabis - Minimizing the Health Risks from Legalization.

Authors:  Beau Kilmer
Journal:  N Engl J Med       Date:  2017-02-23       Impact factor: 91.245

4.  Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.

Authors:  Aine T Behan; Magdalena Hryniewiecka; Colm M P O'Tuathaigh; Anthony Kinsella; Mary Cannon; Maria Karayiorgou; Joseph A Gogos; John L Waddington; David R Cotter
Journal:  Neuropsychopharmacology       Date:  2012-03-21       Impact factor: 7.853

5.  The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).

Authors:  Sarah Tosato; Antonio Lasalvia; Chiara Bonetto; Rodolfo Mazzoncini; Doriana Cristofalo; Katia De Santi; Mariaelena Bertani; Sarah Bissoli; Lorenza Lazzarotto; Giovanna Marrella; Dario Lamonaca; Rosanna Riolo; Francesco Gardellin; Anna Urbani; Michele Tansella; Mirella Ruggeri
Journal:  J Psychiatr Res       Date:  2013-01-04       Impact factor: 4.791

6.  Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence.

Authors:  Leonora E Long; Rose Chesworth; Xu-Feng Huang; Iain S McGregor; Jonathon C Arnold; Tim Karl
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-09       Impact factor: 5.176

7.  Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment.

Authors:  I L Schurov; E J Handford; N J Brandon; P J Whiting
Journal:  Mol Psychiatry       Date:  2004-12       Impact factor: 15.992

Review 8.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

Review 9.  DISC1-binding proteins in neural development, signalling and schizophrenia.

Authors:  Nicholas J Bradshaw; David J Porteous
Journal:  Neuropharmacology       Date:  2010-12-31       Impact factor: 5.250

10.  The CB₁ cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway.

Authors:  C Blázquez; A Chiarlone; L Bellocchio; E Resel; P Pruunsild; D García-Rincón; M Sendtner; T Timmusk; B Lutz; I Galve-Roperh; M Guzmán
Journal:  Cell Death Differ       Date:  2015-02-20       Impact factor: 15.828

View more
  11 in total

1.  l-Theanine Prevents Long-Term Affective and Cognitive Side Effects of Adolescent Δ-9-Tetrahydrocannabinol Exposure and Blocks Associated Molecular and Neuronal Abnormalities in the Mesocorticolimbic Circuitry.

Authors:  Marta De Felice; Justine Renard; Roger Hudson; Hanna J Szkudlarek; Brian J Pereira; Susanne Schmid; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

2.  Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.

Authors:  Yan Jouroukhin; Xiaolei Zhu; Alexey V Shevelkin; Yuto Hasegawa; Bagrat Abazyan; Atsushi Saito; Jonathan Pevsner; Atsushi Kamiya; Mikhail V Pletnikov
Journal:  Biol Psychiatry       Date:  2018-08-16       Impact factor: 13.382

3.  Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.

Authors:  Sarah Beggiato; Alessandro Ieraci; Maria Cristina Tomasini; Robert Schwarcz; Luca Ferraro
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-02-04       Impact factor: 5.067

Review 4.  Advantages and Limitations of Animal Schizophrenia Models.

Authors:  Magdalena Białoń; Agnieszka Wąsik
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

5.  Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies.

Authors:  M Taylor; J Cousijn; F Filbey
Journal:  Curr Addict Rep       Date:  2019-10-24

6.  Brain-Derived Neurotrophic Factor (BDNF) Role in Cannabinoid-Mediated Neurogenesis.

Authors:  Filipa Fiel Ferreira; Filipa F Ribeiro; Rui S Rodrigues; Ana Maria Sebastião; Sara Xapelli
Journal:  Front Cell Neurosci       Date:  2018-11-28       Impact factor: 5.505

7.  Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent.

Authors:  Chelsea R Kasten; Yanping Zhang; Stephen L Boehm
Journal:  Front Behav Neurosci       Date:  2019-02-20       Impact factor: 3.558

8.  Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ9-THC and Ethanol Binge Drinking During Adolescence.

Authors:  Daniel Silva-Peña; Patricia Rivera; Francisco Alén; Antonio Vargas; Leticia Rubio; Nuria García-Marchena; Francisco Javier Pavón; Antonia Serrano; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Front Mol Neurosci       Date:  2019-04-24       Impact factor: 5.639

Review 9.  Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective.

Authors:  Sabrina Rahman Archie; Luca Cucullo
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

Review 10.  Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential.

Authors:  Lina Gao; Yun Zhang; Keenan Sterling; Weihong Song
Journal:  Transl Neurodegener       Date:  2022-01-28       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.